Showing 1 - 10 of 6,825
expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically … assessing the impact of regulation on pharmaceutical R&D expenditures. Methods: We analyze a sample of 20 leading pharmaceutical … companies between 2000 and 2008. The share of sales in Europe serves as a proxy for the degree of pharmaceutical regulation. We …
Persistent link: https://www.econbiz.de/10010526909
Persistent link: https://www.econbiz.de/10011450101
Persistent link: https://www.econbiz.de/10012019907
Persistent link: https://www.econbiz.de/10013373030
patient well-being. A further shift is needed away from repressive measures against consumers, to tighter regulation in the …
Persistent link: https://www.econbiz.de/10012260588
Persistent link: https://www.econbiz.de/10013352698
Persistent link: https://www.econbiz.de/10014330617
Persistent link: https://www.econbiz.de/10011305497
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by …
Persistent link: https://www.econbiz.de/10010223101